Latest News From Lumira Ventures

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome

admin Main Page, Portfolio News

VOS showed statistical superiority to Restasis® on FDA-accepted objective signs of DES 42.9% of VOS subjects vs 18.4% of Restasis® subjects (p=.0055) demonstrated ≥ 10mm improvement in STT at Week 4 Primary endpoint of drop discomfort at 1-minute on Day …

Lumira Ventures. Rebranded.

Ahmed Khan Main Page, Lumira News

Today, Lumira Ventures is excited to debut its new website at www.lumiraventures.com, new branding and change of name from Lumira Capital to Lumira Ventures. Over the past 30 years, Lumira has been at the forefront of the healthcare investment industry. …